Dolmans Marie-Madeleine, Donnez Jacques
Pôle de Recherche en Gynécologie, Institut de Recherche Expérimentale et Clinique (IREC), Université Catholique de Louvain, Brussels, Belgium -
Department of Gynecology, Cliniques Universitaires Saint-Luc, Brussels, Belgium -
Minerva Ginecol. 2018 Aug;70(4):402-407. doi: 10.23736/S0026-4784.18.04232-6. Epub 2018 Apr 11.
Oocyte vitrification and ovarian tissue cryopreservation are two common fertility preservation options. Oocyte vitrification provides the highest yield for women with benign diseases or those seeking fertility preservation for age-related fertility decline. This technique is also indicated for cancer women if cancer treatment can be postponed. Ovarian tissue cryopreservation has some specific indications. There is indeed no other alternative for fertility preservation in prepubertal girls, and in cancer women in whom cancer treatment cannot be postponed. This review focuses on the indications for fertility preservation from malignant diseases to benign conditions to age-related fertility decline.
卵母细胞玻璃化冷冻和卵巢组织冷冻保存是两种常见的生育力保存方法。对于患有良性疾病的女性或因年龄相关生育力下降而寻求生育力保存的女性,卵母细胞玻璃化冷冻的成功率最高。如果癌症治疗可以推迟,该技术也适用于癌症女性。卵巢组织冷冻保存有一些特定的适应症。对于青春期前女孩以及癌症治疗不能推迟的癌症女性,确实没有其他生育力保存的替代方法。本综述重点关注从恶性疾病到良性疾病再到年龄相关生育力下降的生育力保存适应症。